Clinical role of diosmectite in the management of diarrhea

Expert Opinion on Drug Metabolism and Toxicology

Volumn 5, Issue 4, 2009, Pages 433-440

  Guarino, Alfredo ^a   Lo Vecchio, Andrea ^a   Pirozzi, Maria Rosaria ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Diarrhea; Diosmectite; Gastroenteritis; Irritable bowel syndrome; Smectite

Indexed keywords

ALUMINUM HYDROXIDE; ANTACID AGENT; ANTIDIARRHEAL AGENT; DIOSMECTITE; IRINOTECAN; LOPERAMIDE; MAGNESIUM HYDROXIDE; PLACEBO; PROBIOTIC AGENT; SILICON DIOXIDE; UNCLASSIFIED DRUG;

ABDOMINAL DISCOMFORT; ACUTE DIARRHEA; CLINICAL TRIAL; COLITIS; COLORECTAL CANCER; CONSTIPATION; DIARRHEA; DISEASE DURATION; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; DRUG TOLERABILITY; ESOPHAGITIS; GASTRITIS; GASTROENTERITIS; GASTROINTESTINAL SYMPTOM; GASTROINTESTINAL TOXICITY; HUMAN; INFECTIOUS DIARRHEA; INTESTINE INJURY; IRRITABLE COLON; MEDLINE; REVIEW; TREATMENT DURATION; TREATMENT INDICATION; TREATMENT RESPONSE;

ANIMALS; ANTIDIARRHEALS; DIARRHEA; DISEASE MANAGEMENT; HUMANS; SILICATES;

EID: 67649292788     PISSN: 17425255     EISSN: None     Source Type: Journal    
DOI: 10.1517/17425250902865594     Document Type: Review

References (48)

1. Wingate D, Phillips SF, Lewis SJ, et al. Guidelines for adults on self-medication for the treatment of acute diarrhoea. Aliment Pharmacol Ther 2001;15:773-782 (Pubitemid 32500423)
2. Guarino A, Albano F, Askenazi S, et al. European society for paediatric gastroenterology, hepatology, and nutrition/European society for paediatric infectious diseases evidence-based guidelines for the management of acute gastroenteritis in children in Europe. J Pediatr Gastroenterol Nutr 2008;46:S81-122 •• A recent and authoritative evidence-based document for the management of acute gastroenteritis in pediatric age and the first guideline that considers smectite and other active interventions as an adjunct therapy together with oral rehydration for the management of diarrhea in children. (Pubitemid 351644171)
3. Provisional committee on quality improvement: subcommittee on acute gastroenteritis. Practice parameter: the management of acute gastroenteritis in young children. Pediatrics 1996;97:424-436 (Pubitemid 26077989)
4. Manatsathit S, Dupont HL, Farthing M, et al. Guideline for the management of acute diarrhea in adults. J Gastroenterol Hepatol 2002;17:S54-71 (Pubitemid 34539298)
5. Li ST, Grossman DC, Cummings P. Loperamide therapy for acute diarrhea in children: systematic review and meta-analysis. PLoS Med 2007;4:e98 (Pubitemid 46495317)
6. Salazar-Lindo E, Santisteban-Ponce J, Chea-Woo E, et al. Racecadotril in the treatment of acute watery diarrhea in children. N Engl J Med 2000;343:463-467 (Pubitemid 30646485)
7. Cezard JP, Duhamel JF, Meyer M, et al. Efficacy and tolerability of racecadotril in acute diarrhea in children. Gastroenterology 2001;120:799-805 (Pubitemid 32193175)
8. Cojocaru B, Bocquet N, Timsit S, et al. Effect of racecadotril in the management of acute diarrhea in infants and children. Arch Pediatr 2002;9:774-779 (Pubitemid 34982635)
9. Guarino A, Lo Vecchio A, Canani RB. Probiotics as prevention and treatment for diarrhea. Curr Opin Gastroenterol 2009;25:18-23
10. DuPont HL, Sullivan P, Pickering LK, et al. Symptomatic treatment of diarrhea with bismuth subsalicylate among students attending a Mexican university. Gastroenterology 1977;73:715-718 (Pubitemid 8210065)
11. Figueroa-Quintanilla D, Salazar-Lindo E, Sack RB, et al. A controlled trial of bismuth subsalicylate in infants with acute watery diarrheal disease. N Engl J Med 1993;328:1653-1658 (Pubitemid 23157346)
12. Chowdhury HR, Yunus M, Zaman K, et al. The efficacy of bismuth subsalicylate in the treatment of acute diarrhoea and the prevention of persistent diarrhoea. Acta Paediatr 2001;90:605-610 (Pubitemid 32595861)
13. Szajewska H, Hoekstra JH, Sandhu B. Management of acute gastroenteritis in Europe and the impact of the new recommendations:a multicenter study. The Working Group on Acute Diarrhoea of the European Society for Paediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr 2000;30:522-527
14. Sandhu BK. Practical guidelines for the management of gastroenteritis in children. J PediatrGastroenterol Nutr 2001;33:S36-9 (Pubitemid 33070123)
15. The treatment of diarrhea: practical guidelines. Geneva, Switzerland: World Health Organisation; 1993
16. Practice parameter: the management of acute gastroenteritis in young children. American academy of pediatrics, provisional committee on quality improvement, subcommittee on acute gastroenteritis. Pediatrics 1996;97:424-435
17. King CK, Glass R, Bresee JS, et al. Managing acute gastroenteritisamong children: oral rehydration, maintenance, and nutritional therapy. MMWR Recomm Rep 2003;52:1-16
18. Albengres E, Urien S, Tillement JR, et al. Interactions between smectite, a mucus stabilizer, and acidic and basic drugs. In vitro and in vivo studies. Eur J Clin Pharmacol 1985;28:601-605
19. Fioramonti J, Fargeas MJ, Bueno L, Droy-Lefaix MT. Action of T-2 toxin on gastrointestinal transit in mice: protective effect of an argillaceous compound. Toxicol Lett 1987;36:227-232 (Pubitemid 17111205)
20. Kheroua O, Jutteau J, Tome D, Desjeux JF. Action de la smectite en presence de la toxine cholerique et de la solution de rehydratation sur les mouvements d'eau et d'electrolytes dans l'intestin du rat. Gastroenterol Clin Biol 1987;11:240A
21. Navetat H, Droy MT, Espinasse J. Infection experimentale du veau par le colibacille K99+: effet protecteur de la smectite. Bulletin de l'Academie Vetrinnaire de. France 1988;61:365-375
22. Brouillard MY, Rateau JG. Adsorption potency of 2 clays, smectite and kaolin on bacterial enterotoxins. In vitro study in cell culture and in the intestine of newborn mice. Gastroenterol Clin Biol 1989;13:18-24
23. Rey C. Diarrhees virales a rotavirus. Interet de la Smectite. Revue Internationale de. Pediatrics 1989;15:33-37
24. Dupont C, Moreno JL, Barau E, et al. Effect of diosmectite on intestinal permeability changes in acute diarrhea: a double-blind placebo-controlled trial. J Pediatr Gastroenterol Nutr 1992;14:413-419
25. Vermeulen L, Droy-Lefaix M, Rampal P. In vitro study of the effects of dioctahedric smectite on the induction of cyclic AMP by cholerotoxin. In: Proceedings of IX World Congresses of Gastroenterology. Sydney: 1990
26. Fioramonti J, Droy-Lefaix MT, Bueno L. Changes in gastro-intestinal motility induced by cholera toxin and experimental osmotic diarrhoea in dogs: effects of treatment with an argillaceous compound. Digestion 1987;36:230-237 (Pubitemid 17073607)
27. Droy MT, Drouet Y, Geraud G, et al. Spinnability: a new approach to intestinal stress and its therapy. Gastroenterol Clin Biol 1985;9:119-121 (Pubitemid 16179016)
28. Morè J, Benazet F, Fioramonti J, et al. Effects of treatment with smectite on gastric and intestinal glycoproteins in the rat: a histochemical study. Histochem J 1987;19:665-670
29. Rateau JG, Morgant G, Droy-Priot MT, Parier JL. A histological, enzymatic and water-electrolyte study of the action of smectite, a mucoprotective clay, on experimental infectious diarrhoea in the rabbit. Curr Med Res Opin 1982;8:233-234 (Pubitemid 13209302)
30. Mahraoui L, Heyman M, Plique O, et al. Apical effect of diosmectite on damage to the intestinal barrier induced by basal tumour necrosis factor-alpha. Gut 1997;40:339-343 • An excellent paper describing an innovative mechanism of the epithelial trophic effects by diosmectite. (Pubitemid 27145646)
31. González R, de Medina FS, Martínez-Augustin O, et al. Anti-inflammatory effect of diosmectite in hapten-induced colitis in the rat. Br J Pharmacol 2004;141(6):951-960 [Epub 2004 Mar 1] (Pubitemid 38510078)
32. Leonard A, Droy-Lefaix MT, Allen A. Pepsin hydrolysis of the adherent mucus barrier and subsequent gastric mucosal damage in the rat: effect of diosmectite and 16,16 dimethyl prostaglandin E2. Gastroenterol Clin Biol 1994;18:609-616 (Pubitemid 24261421)
33. Theodorou V. Fioramonti J, Droy-Lefaix MT, Plique O, Bueno L. Protective action of diosmectite treatment on digestive disturbances induced by intestinal anaphylaxisin the guinea-pig. Aliment Pharnacol Ther 1994;8:295-299 (Pubitemid 24205528)
34. Castela-Papin N, Cai S, Vatier J, et al. Drug interactions with diosmectite: a study using the artificial stomach-duodenum model. Int J Pharm 1999;182:111-119 (Pubitemid 29229799)
35. Szajewska H, Dziechciarz P, Mrukowicz J. Meta-analysis: Smectite in the treatment of acute infectious diarrhoea in children. J Aliment Pharmacol Ther 2006;23(2):217-227 •• A recent meta-analysis that provides well-supported information on the effectiveness of smectite in treating acute infectious diarrhea in children. (Pubitemid 43382030)
36. Lexomboon U, Harikul S, Lortholary O. Control randomized study of rehydration/rehydration with dioctahedral smectite in ambulatory Thai infants with acute diarrhea. Southeast Asian J Trop Med Public Health 1994;25(1):157-162
37. Vivatvakin B, Jongpipatvanich S, Harikul S, et al. Control study of oral rehydration solution (ORS)/ORS + dioctahedral smectite in hospitalized Thai infants with acute secretory diarrhea. Southeast Asian J Trop Med Public Health 1992;23(3):414-419 (Pubitemid 23034537)
38. Guarino A, Bisceglia M, Castellucci G, et al. Smectite in the treatment of acute diarrhea: a nationwide randomized controlled study of the Italian society of pediatric gastroenterology and hepatology (SIGEP) in collaboration With primary care pediatricians. JPGN 2001;32:71-75 • The largest pediatric RCT evaluating efficacy and tolerance of treatment with smectite in an outpatient setting. (Pubitemid 32094501)
39. Leber W. A new suspension form of smectite (Liquid 'Diasorb') for the treatment of acute diarrhoea: a randomized comparative study. Pharmatherapeutica 1988;5(4):256-260
40. Yen ZS, Lai MS. Smectite for acute diarrhoea in children. Emerg Med J 2006;23:65-66 (Pubitemid 43056372)
41. Rasqiun A, Di Lorenzo C, Forbes D, et al. Childhood functional gastrointestinal disorders: child/adolescent. Gastroenterology 2006;130:1527-1537
42. Chang FY, Lu CL, Chen CY, Luo JC. Efficacy of dioctahedral smectite in treating patients of diarrhea-predominant irritable bowel syndrome. J Gastroenterol Hepatol 2007;22:2266-2272 (Pubitemid 350145630)
43. Dumitrascu DL, Stanculete M, Mitrea I, et al. The effect of two antidiarrhoeal drugs on the psychosocial adjustment to illness in chronic functional diarrhea. Rom J Intern Med 2004;42(1):191-197 (Pubitemid 39621239)
44. Yao-Zong Y, Shi-Rong L, Delvaux M. Comparative efficacy of dioctahedral smectite (Smecta) and a probiotic preparation in chronic functional diarrhoea. Dig Liver Dis 2004;36:824-828 (Pubitemid 41070582)
45. Duffour J, Gourgou S, Seitz JF, et al. Efficacy of prophylactic anti-diarrhoeal treatment in patients receiving Campto for advanced colorectal cancer. Anticancer Res 2002;22:3727-3731 (Pubitemid 36132857)
46. Classen J, Belka C, Paulsen F, et al. Radiation-induced gastrointestinal toxicity. Pathophysiology, approaches to treatment and prophylaxis. Strahlenther Onkol 1998;174(Suppl 3):82-84
47. Lichtenstein H. Antacid therapy of upper abdominal symptoms. Double-blind study on the effect and tolerance of 2 antacids in gastritis, esophagitis and functional upper abdominal symptoms. Fortschr Med 1991;109528-109532
48. Kurtz W. Role of bile acids in the development of peptic lesions. Studies on the bile acid-binding capacity of a new kind of antacid. Fortschr Med 1991;109:592-594